Overactive Bladder - Results from #200

Longitudinal follow-up of bladder function in children who participated in the Swedish Reflux Trial. October 15, 2023

The use of Metformin in overactive bladder - a retrospective nested case-control, population-based analysis. October 15, 2023

Comparative Study Between Behavior Therapy and Behavior Therapy Plus Mirabegron 50 mg in Sexually Active Men With Bothersome Overactive Bladder Symptoms - A Multicenter, Randomized Study. October 8, 2023

Analyzing Access and Costs of Oral Medications for Overactive Bladder (OAB): Uncovering Disparities. October 8, 2023

Naturalistic Bladder Filling Reveals Subtypes in Overactive Bladder Syndrome That Differentially Engages Urinary Urgency-Related Brain Circuits: Results From the Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN). October 8, 2023

Bladder training compared to bladder training associated with pelvic floor muscle training for overactive bladder symptoms in women: A randomized clinical trial. October 1, 2023

Efficacy and safety of an alternative onabotulinumtoxinA injection paradigm for refractory overactive bladder. October 1, 2023

The Role of Sarcopenia in Overactive Bladder in Adults in the United States: Retrospective Analysis of NHANES 2011-2018. October 1, 2023

Patient and Clinician Challenges with Anticholinergic Step Therapy in the Treatment of Overactive Bladder: A Narrative Review. September 24, 2023

Impact of Sling at Time of Prolapse Surgery on Overactive Bladder. September 24, 2023

Device evaluation: eCoin- implantable tibial nerve stimulator for overactive bladder. September 17, 2023

Vibegron shows high selectivity and potent agonist activity for β3-adrenoceptors, irrespective of receptor density. September 10, 2023

Systematic review and meta-analysis of urinary incontinence prevalence and population estimates. September 10, 2023

A positive association between the prevalence of circadian syndrome and overactive bladder in United States adults. September 3, 2023

Pelvic floor dysfunction and obesity. September 3, 2023

Associations of Clinical and Dosimetric Parameters with Urinary Toxicities after Prostate Brachytherapy: A Long-Term Single-Institution Experience. September 3, 2023

Assessment of prescribing practices in overactive bladder pharmacotherapy across different specialties of India: a prescription trend analysis. August 27, 2023

Weak association between arterial hypertension and overactive bladder baseline symptoms and treatment responses. August 27, 2023

Intravesical Injection of Botulinum Toxin Type A in Patients with Refractory Overactive Bladder-Results between Young and Elderly Populations, and Factors Associated with Unfavorable Outcomes. August 27, 2023

Plain language summary of safety and symptom improvement with vibegron in people with overactive bladder: results from the EMPOWUR study. August 20, 2023

Page 11 of 122